SBC Medical Group

SBC

Market cap $429M

TOKYO--(BUSINESS WIRE)-- #Healthcare--The final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937).

New York, New York--(Newsfile Corp. - December 1, 2025) - Emerging Growth Research today announced the release of its Q3:25 quarterly update on SBC Medical Group Holdings, Inc. (NASDAQ: SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing significant upside from the Company's recent closing price of $3.57 on November 28, 2025. The quarterly update highlights SBC's sequential stabilization in revenue and operating profit during Q3:25, strong cash position, and the Company's positioning for renewed growth beginning in early 2026 as it works through near-term competitive pressures.

IRVINE, Calif.--(BUSINESS WIRE)-- #Medical--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriate.

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Financial results for Q3 FY2025 and the year-to-date period (nine months ended September 30, 2025).

TOKYO--(BUSINESS WIRE)-- #Healthcare--November 13, 2025, SBC resolved to acquire shares of Waqoo, Inc. (Code: 4937), a Tokyo Stock Exchange Growth Market company, through a tender offer.

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. Earnings call on Monday, November 17, 2025.

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC's multi.

New York, New York--(Newsfile Corp. - September 4, 2025) - Emerging Growth Research today announced the initiation of coverage on SBC Medical Group Holdings, Inc. (NASDAQ: SBC) with a Buy-Extended rating and a 12-month price target of $9.00, more than double the Company's recent closing price of $4.06. The initiation report highlights SBC's dominant position in Japan's cosmetic treatment industry, its strong cash position, and growing global expansion strategy, while also acknowledging near-term revenue pressures due to pricing competition in the domestic market.

IRVINE, Calif.--(BUSINESS WIRE)-- #Medical--SBC Medical will deliver large presentations and conduct one-on-one meetings with institutional investors.

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that Dr. Ewen Chee, founder of Singapore's leading aesthetic medical company Aesthetic Healthcare Holdings (“AHH”), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitm.